Campaign Opens Up Collaboration Opportunities Around Rare Disease Diversity
Executive Summary
NORD’s director of membership talks about how companies focused on rare diseases can partner with often under-resourced non-profits on diversity initiatives.
You may also be interested in...
How Little Moderna Made Big Waves In Trial Diversity
Early on, the company committed to transparency while making sure its Phase III vaccine study enrolled a population reflective of the US as a whole. Moderna talks to Scrip about the experience.
Decentralized Trials Ease Enrollment In Rare Disease Studies
Panel discussion illustrated how decentralized approaches can expand the possibilities of studies in rare diseases, such as cancers with rare genomic alterations.